Seizure control: a secondary benefit of chemotherapeutic temozolomide in brain cancer patients.

Abstract

The severity of brain tumor associated seizures often mirror the growth of the underlying tumor, and may be intractable to conventional antiepileptic drugs. We present a patient with intractable seizures in the setting of a low grade glioma who responded dramatically to temozolomide despite minimal radiographic change in tumor size. Temozolomide is an effective treatment for seizure control in patients with brain tumors.

DOI: 10.1016/j.eplepsyres.2011.03.018

Cite this paper

@article{Hu2011SeizureCA, title={Seizure control: a secondary benefit of chemotherapeutic temozolomide in brain cancer patients.}, author={Alexander Hu and Zhiqiang Xu and Ryan Y. Kim and Angel Nguyen and Jong Woo Lee and Santosh Kesari}, journal={Epilepsy research}, year={2011}, volume={95 3}, pages={270-2} }